Top Markets
Coin of the day
NanoVibronix, Inc. NanoVibronix, Inc.

NanoVibronix, Inc.

NAOV
Rangering i aksjer #37687
NanoVibronix, Inc., operating through its subsidiary NanoVibronix Ltd.,... NanoVibronix, Inc., operating through its subsidiary NanoVibronix Ltd., develops and commercializes innovative, non-invasive devices that stimulate biological responses for therapeutic purposes. Their core focus areas include mitigating biofilm formation, accelerating wound repair, and alleviating pain. Key among their product line is UroShield, an ultrasound-based solution engineered to deter bacterial colonization and biofilm development in urinary catheters, thereby boosting antibiotic efficacy and reducing associated patient discomfort. They also offer PainShield and WoundShield, both patch-based therapeutic ultrasound technologies. PainShield targets relief from pain, muscle spasms, and joint contractures, while WoundShield is designed to foster tissue regeneration and promote healing in wounds. The company distributes these products directly to consumers and via extensive distributor networks spanning the United States, Israel, Europe, India, and numerous other international regions. Founded in 2003, NanoVibronix, Inc. maintains its corporate headquarters in Elmsford, New York.
Aksjekurs
$1.90
Sist synkronisert: 2026-03-11
Markedsverdi
$1.51M
Endring (1 dag)
-41.54%
Endring (1 år)
-67.58%
Land
US
Handel NanoVibronix, Inc. (NAOV)

Kategori

EPS for NanoVibronix, Inc. (NAOV)
EPS per 2026 TTM: 0
Ifølge de siste økonomiske rapportene og aksjekursen til NanoVibronix, Inc. er selskapets nåværende EPS (TTM) 0. Ved slutten av 2026 hadde selskapet en EPS på 0, lik EPS-en i 2026 som var 0.
EPS-historikk for NanoVibronix, Inc. fra 2026 til 2026
EPS ved slutten av hvert år
År EPS Endre
Ikke nok data for de angitte datoene.
EPS for lignende selskaper eller konkurrenter